Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - TAURIGA SCIENCES, INC. | imun_8k.htm |
| EX-99 - LETTER - TAURIGA SCIENCES, INC. | imun_ex99.htm |
EXHIBIT 16
February 28, 2013
Securities and Exchange Commission
Washington, D.C. 20549
Commissioners:
We have read Immunovative, Inc. statements included under Item 4.01 of its Form 8-K filed on February 28, 2013 and we agree with such statements concerning our firm.
Meyler & Company, LLC